Background Cognitive symptoms after coronavirus disease 2019 (Covid-19), the disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are well …

Abstract Objective COVID-19 (SARS-CoV-2) has been associated with neurological
sequelae even in those patients with mild respiratory symptoms. Patients experiencing …

As the heterogeneity of symptoms is increasingly recognized among long-COVID patients, it
appears highly relevant to study potential pathophysiological differences along the different …

The reduced pathogenicity of the omicron BA. 1 sub-lineage compared to earlier variants is
well described, although whether such attenuation is retained for later variants like BA. 5 …

The elderly and those with underlying chronic diseases (ie, comorbidities) such as
pulmonary, cardiovascular, metabolic, and renal diseases, increase their susceptibility to …

Cohort studies that quantify volumetric brain data among individuals with different levels of
COVID-19 severity are presently limited. It is still uncertain whether there exists a potential …

Post-COVID-19 syndrome is a serious complication following SARS-CoV-2 infection,
characterized primarily by fatigue and cognitive complaints. Although first metabolic and …

Immune cells and cytokines are largely recognized as significant factors in the
pathophysiology of neuropsychiatric disorders. The possible role of other blood cells such …

COVID-19 remains a significant international public health concern. Yet, the mechanisms
through which symptomatology emerges remain poorly understood. While SARS-CoV-2 …

Abstract Coronavirus disease 2019 (COVID-19) has been associated with brain functional,
structural, and cognitive changes that persist months after infection. Most studies of the …